Sernova Corp. (TSE:SVA – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Monday . The company traded as low as C$0.16 and last traded at C$0.17, with a volume of 499410 shares changing hands. The stock had previously closed at C$0.18.
Sernova Stock Performance
The firm has a market cap of C$55.52 million, a price-to-earnings ratio of -1.59 and a beta of 1.35. The company has a debt-to-equity ratio of -4.40, a current ratio of 0.32 and a quick ratio of 18.11. The business has a 50-day moving average of C$0.20 and a 200-day moving average of C$0.23.
Sernova Company Profile
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Recommended Stories
- Five stocks we like better than Sernova
- Industrial Products Stocks Investing
- Energy Transfer: Powering Data With Dividends and Diversification
- Retail Stocks Investing, Explained
- Qualcomm Stock Is Coiling for a Breakout
- How to Calculate Return on Investment (ROI)
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
